CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Roxithromycin results in decreased expression of BCL2 protein
CTD
PMID:12921874
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
decreases activity
ISO
Roxithromycin results in decreased activity of CYP2B6 protein
CTD
PMID:17164692
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions decreases expression decreases activity
ISO
Roxithromycin inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone] Roxithromycin results in decreased expression of CYP3A4 mRNA Roxithromycin results in decreased activity of CYP3A4 protein
CTD
PMID:16416302 PMID:16837568 PMID:17164692
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
G
Faslg
Fas ligand
increases expression
ISO
Roxithromycin results in increased expression of FASLG protein
CTD
PMID:12921874
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Roxithromycin results in increased expression of FOS mRNA; Roxithromycin results in increased expression of FOS protein
CTD
PMID:32454074
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Il1b
interleukin 1 beta
multiple interactions
ISO EXP
Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of IL1B mRNA]; Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of IL1B protein] Roxithromycin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
CTD
PMID:17524151 PMID:18197913
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of IL6 mRNA]; Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of IL6 protein]
CTD
PMID:17524151
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Itgb4
integrin subunit beta 4
decreases expression
ISO
Roxithromycin results in decreased expression of ITGB4 protein
CTD
PMID:14687228
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
G
Lamc2
laminin subunit gamma 2
decreases expression
ISO
Roxithromycin results in decreased expression of LAMC2 protein
CTD
PMID:14687228
NCBI chr13:65,284,664...65,344,200
Ensembl chr13:65,284,664...65,344,200
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
multiple interactions
EXP
Roxithromycin inhibits the reaction [Lipopolysaccharides results in increased expression of MUC5AC mRNA]; Roxithromycin inhibits the reaction [Lipopolysaccharides results in increased expression of MUC5AC protein]
CTD
PMID:18197913
NCBI chr 1:196,864,375...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
EXP
Roxithromycin inhibits the reaction [Diethylnitrosamine results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:16061884
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO EXP
Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of NOS2 protein] Roxithromycin inhibits the reaction [Diethylnitrosamine results in increased activity of NOS2 protein]
CTD
PMID:16061884 PMID:17524151
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Roxithromycin inhibits the reaction [Diethylnitrosamine results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:16061884
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of TNF mRNA]; Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of TNF protein] Roxithromycin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:17524151 PMID:18197913
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
ISO
Erythromycin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Erythromycin results in decreased activity of ABCB11 protein
CTD
PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions affects transport
ISO EXP
Erythromycin inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine]; Erythromycin inhibits the reaction [ABCB1 protein results in increased transport of quinidinium] ABCB1 protein affects the transport of Erythromycin
CTD
PMID:12235267 PMID:15304119 PMID:25268938
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Acaca
acetyl-CoA carboxylase alpha
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of ACACA mRNA Erythromycin results in increased expression of ACACA mRNA
CTD
PMID:27503388
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acly
ATP citrate lyase
increases expression multiple interactions
ISO
Erythromycin results in increased expression of ACLY mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of ACLY mRNA
CTD
PMID:27503388
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Erythromycin results in increased expression of ASAH1 mRNA
CTD
PMID:17175557
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
decreases expression
ISO
Erythromycin results in decreased expression of ASNS mRNA
CTD
PMID:17175557
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Casp3
caspase 3
multiple interactions increases activity
ISO
[Erythromycin co-treated with IL1B protein] results in increased activity of CASP3 protein; [Erythromycin co-treated with IL6 protein] results in increased activity of CASP3 protein; [Erythromycin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] inhibits the reaction [Erythromycin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
ISO
[Benzoyl Peroxide co-treated with Erythromycin] results in decreased activity of CAT protein
CTD
PMID:11809596
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
increases expression multiple interactions
ISO
Erythromycin results in increased expression of CCL2 mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of CCL2 mRNA
CTD
PMID:27503388
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
increases expression multiple interactions
ISO
Erythromycin results in increased expression of CCR2 mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of CCR2 mRNA
CTD
PMID:27503388
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cd34
CD34 molecule
increases expression
ISO
Erythromycin results in increased expression of CD34 protein
CTD
PMID:16297520
NCBI chr13:106,480,074...106,499,462
Ensembl chr13:106,480,043...106,499,832
G
Cd36
CD36 molecule
increases expression multiple interactions
ISO
Erythromycin results in increased expression of CD36 mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of CD36 mRNA
CTD
PMID:27503388
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CPT1A mRNA Erythromycin results in increased expression of CPT1A mRNA
CTD
PMID:27503388
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Crp
C-reactive protein
increases expression multiple interactions
ISO
Erythromycin results in increased expression of CRP mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of CRP mRNA
CTD
PMID:27503388
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
G
Cs
citrate synthase
increases expression multiple interactions
ISO
Erythromycin results in increased expression of CS mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of CS mRNA
CTD
PMID:27503388
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
Erythromycin results in increased expression of CXCR4 protein
CTD
PMID:19502290
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyp11b3
cytochrome P450, family 11, subfamily b, polypeptide 3
increases expression
ISO
Erythromycin results in increased expression of CYP11B2
CTD
PMID:17822730
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases activity
ISO
Erythromycin results in decreased activity of CYP2C29 protein
CTD
PMID:18420780
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
decreases activity
ISO
Erythromycin results in decreased activity of CYP2D22 protein
CTD
PMID:18420780
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases methylation increases metabolic processing affects metabolic processing decreases activity increases expression multiple interactions
ISO
CYP3A4 protein results in decreased methylation of Erythromycin CYP3A4 protein results in increased metabolism of Erythromycin CYP3A4 protein affects the metabolism of Erythromycin Erythromycin results in decreased activity of CYP3A4 protein Erythromycin results in increased expression of CYP3A4 mRNA; Erythromycin results in increased expression of CYP3A4 protein Erythromycin inhibits the reaction [CYP3A4 protein affects the metabolism of brotizolam]; Erythromycin inhibits the reaction [CYP3A4 protein results in decreased methylation of Etoposide]; Erythromycin inhibits the reaction [CYP3A4 protein results in decreased methylation of Teniposide]; Erythromycin inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; Erythromycin inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]; IFNA protein inhibits the reaction [CYP3A4 protein results in increased metabolism of Erythromycin]
CTD
PMID:2271712 PMID:8114683 PMID:15383492 PMID:15466163 PMID:15845683 PMID:16041596 PMID:16042670 PMID:16416302 PMID:18505790 PMID:19299527 PMID:21466820 More...
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases methylation
ISO
CYP3A5 protein results in decreased methylation of Erythromycin
CTD
PMID:15383492
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Defb1
defensin beta 1
decreases expression multiple interactions
ISO
Erythromycin results in decreased expression of DEFB1 mRNA [Penicillin G co-treated with Erythromycin] results in decreased expression of DEFB1 mRNA
CTD
PMID:27503388
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
G
Depp1
DEPP autophagy regulator 1
increases expression
ISO
Erythromycin results in increased expression of DEPP1 mRNA
CTD
PMID:17175557
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Dgat1
diacylglycerol O-acyltransferase 1
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of DGAT1 mRNA
CTD
PMID:27503388
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
G
Dgat2
diacylglycerol O-acyltransferase 2
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of DGAT2 mRNA
CTD
PMID:27503388
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Fabp1
fatty acid binding protein 1
increases expression multiple interactions
ISO
Erythromycin results in increased expression of FABP1 mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of FABP1 mRNA
CTD
PMID:17175557 PMID:27503388
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fasn
fatty acid synthase
increases expression multiple interactions
ISO
Erythromycin results in increased expression of FASN mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of FASN mRNA
CTD
PMID:27503388
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fndc4
fibronectin type III domain containing 4
decreases expression
ISO
Erythromycin results in decreased expression of FNDC4 mRNA
CTD
PMID:17175557
NCBI chr 6:25,077,155...25,080,812
Ensembl chr 6:25,077,349...25,080,675
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Erythromycin results in increased expression of FOS mRNA; Erythromycin results in increased expression of FOS protein
CTD
PMID:32454074
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
increases expression multiple interactions
ISO
Erythromycin results in increased expression of GPAM mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of GPAM mRNA
CTD
PMID:27503388
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
Erythromycin inhibits the reaction [Particulate Matter results in increased expression of HMOX1 mRNA]; Erythromycin inhibits the reaction [Vehicle Emissions results in increased expression of HMOX1 mRNA]
CTD
PMID:23291319
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hpn
hepsin
increases expression
ISO
Erythromycin results in increased expression of HPN mRNA
CTD
PMID:17175557
NCBI chr 1:86,337,085...86,352,785
Ensembl chr 1:86,337,087...86,352,811
G
Hrh1
histamine receptor H 1
multiple interactions
EXP
[Diphenhydramine results in decreased activity of HRH1 protein] which results in decreased susceptibility to Erythromycin
CTD
PMID:12856827
NCBI chr 4:147,564,781...147,649,353
Ensembl chr 4:147,645,995...147,647,455
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
Erythromycin results in increased expression of ICAM1 protein
CTD
PMID:14729754 PMID:16297520
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifng
interferon gamma
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of IFNG mRNA Erythromycin results in increased expression of IFNG mRNA
CTD
PMID:27503388
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il1a
interleukin 1 alpha
increases expression multiple interactions
ISO
Erythromycin results in increased expression of IL1A mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of IL1A mRNA
CTD
PMID:27503388
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Erythromycin co-treated with IL1B protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] inhibits the reaction [Erythromycin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
increases expression multiple interactions
ISO
Erythromycin results in increased expression of IL6 mRNA [Erythromycin co-treated with IL6 protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] inhibits the reaction [Erythromycin results in increased activity of CASP3 protein] [Penicillin G co-treated with Erythromycin] results in increased expression of IL6 mRNA
CTD
PMID:27503388 PMID:30876886
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inhbe
inhibin subunit beta E
increases expression
ISO
Erythromycin results in increased expression of INHBE mRNA
CTD
PMID:17175557
NCBI chr 7:63,177,558...63,178,983
Ensembl chr 7:63,176,219...63,179,172
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
affects binding decreases activity multiple interactions
ISO
Erythromycin binds to KCNH2 protein Erythromycin results in decreased activity of KCNH2 protein Erythromycin affects the reaction [KCNH2 protein results in decreased susceptibility to Doxorubicin]; Erythromycin binds to and results in decreased activity of KCNH2 protein
CTD
PMID:15272206 PMID:16086867 PMID:18701618 PMID:24052561
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Lbp
lipopolysaccharide binding protein
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of LBP mRNA
CTD
PMID:27503388
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lss
lanosterol synthase
increases expression
ISO
Erythromycin results in increased expression of LSS mRNA
CTD
PMID:17175557
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Mttp
microsomal triglyceride transfer protein
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of MTTP mRNA
CTD
PMID:27503388
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Muc2
mucin 2, oligomeric mucus/gel-forming
decreases expression multiple interactions
ISO
Erythromycin results in decreased expression of MUC2 mRNA [Penicillin G co-treated with Erythromycin] results in decreased expression of MUC2 mRNA
CTD
PMID:27503388
NCBI chr 1:196,796,257...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
Erythromycin inhibits the reaction [Particulate Matter results in increased activity of NFE2L2 protein]; Erythromycin inhibits the reaction [Vehicle Emissions results in increased activity of NFE2L2 protein]
CTD
PMID:23291319
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
increases expression multiple interactions
ISO
Erythromycin results in increased expression of NFKB1 mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of NFKB1 mRNA
CTD
PMID:27503388
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
Erythromycin inhibits the reaction [Particulate Matter results in increased expression of NQO1 mRNA]; Erythromycin inhibits the reaction [Vehicle Emissions results in increased expression of NQO1 mRNA]
CTD
PMID:23291319
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression decreases expression
ISO
Erythromycin results in increased expression of NUPR1 mRNA Erythromycin results in decreased expression of NUPR1 mRNA
CTD
PMID:17175557
NCBI chr 1:181,213,292...181,215,327
G
Pla2g2a
phospholipase A2 group IIA
decreases expression
ISO
Erythromycin results in decreased expression of PLA2G2A mRNA
CTD
PMID:27503388
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
G
Reg3g
regenerating family member 3 gamma
multiple interactions decreases expression
ISO
[Penicillin G co-treated with Erythromycin] results in decreased expression of REG3G mRNA Erythromycin results in decreased expression of REG3G mRNA
CTD
PMID:27503388
NCBI chr 4:110,922,805...110,927,803
Ensembl chr 4:110,924,168...110,926,723
G
Retnlb
resistin like beta
multiple interactions decreases expression
ISO
[Penicillin G co-treated with Erythromycin] results in decreased expression of RETNLB mRNA Erythromycin results in decreased expression of RETNLB mRNA
CTD
PMID:27503388
NCBI chr11:51,983,482...51,985,368
Ensembl chr11:51,983,483...51,985,368
G
RT1-CE16
RT1 class I, locus CE16
affects expression
ISO
Erythromycin affects the expression of HLA-A mRNA
CTD
PMID:25811541
NCBI chr20:3,257,752...3,260,683
Ensembl chr20:3,257,123...3,279,563
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
affects expression
ISO
Erythromycin affects the expression of HLA-G mRNA
CTD
PMID:25811541
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
Scd
stearoyl-CoA desaturase
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of SCD1 mRNA Erythromycin results in increased expression of SCD1 mRNA
CTD
PMID:27503388
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sele
selectin E
increases expression
ISO
Erythromycin results in increased expression of SELE protein
CTD
PMID:16297520
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Sell
selectin L
increases expression
ISO
Erythromycin results in increased expression of SELL protein
CTD
PMID:16297520
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Slc22a7
solute carrier family 22 member 7
multiple interactions
ISO
Erythromycin inhibits the reaction [SLC22A7 protein results in increased transport of Tetracycline] Erythromycin inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates]
CTD
PMID:12065749 PMID:15901346
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Slc27a2
solute carrier family 27 member 2
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of SLC27A2 mRNA
CTD
PMID:27503388
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
G
Srebf1
sterol regulatory element binding transcription factor 1
increases expression multiple interactions
ISO
Erythromycin results in increased expression of SREBF1 mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of SREBF1 mRNA
CTD
PMID:27503388
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Tagln
transgelin
decreases expression
ISO
Erythromycin results in decreased expression of TAGLN mRNA
CTD
PMID:17567588
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tlr4
toll-like receptor 4
increases expression multiple interactions
ISO
Erythromycin results in increased expression of TLR4 mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of TLR4 mRNA
CTD
PMID:27503388
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
increases expression multiple interactions
ISO
Erythromycin results in increased expression of TNF mRNA [Erythromycin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] inhibits the reaction [Erythromycin results in increased activity of CASP3 protein] [Penicillin G co-treated with Erythromycin] results in increased expression of TNF mRNA
CTD
PMID:27503388 PMID:30876886
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vcam1
vascular cell adhesion molecule 1
increases expression
ISO
Erythromycin results in increased expression of VCAM1 protein
CTD
PMID:16297520
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
Erythromycin results in increased expression of WIPI1 mRNA
CTD
PMID:17175557
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Abcb11
ATP binding cassette subfamily B member 11
decreases expression decreases activity
EXP ISO
Erythromycin Estolate results in decreased expression of ABCB11 mRNA Erythromycin Estolate results in decreased activity of ABCB11 protein
CTD
PMID:17522070 PMID:20829430 PMID:23956101 PMID:28437613
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
EXP
Erythromycin Estolate results in increased expression of ABCB1 mRNA; Erythromycin Estolate results in increased expression of ABCB1A mRNA
CTD
PMID:17522070 PMID:24412560
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc3
ATP binding cassette subfamily C member 3
increases expression
EXP
Erythromycin Estolate results in increased expression of ABCC3 mRNA
CTD
PMID:17522070 PMID:24412560
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression
EXP
Erythromycin Estolate results in increased expression of ABCG5 mRNA
CTD
PMID:24412560
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
increases expression
EXP
Erythromycin Estolate results in increased expression of ABCG8 mRNA
CTD
PMID:24412560
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Acadm
acyl-CoA dehydrogenase medium chain
decreases expression
EXP
Erythromycin Estolate results in decreased expression of ACADM mRNA
CTD
PMID:17522070
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
G
Acly
ATP citrate lyase
decreases expression
EXP
Erythromycin Estolate results in decreased expression of ACLY mRNA
CTD
PMID:17522070
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of ACSL1 mRNA
CTD
PMID:17522070
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
EXP
Erythromycin Estolate results in increased expression of ALDH1A1 mRNA
CTD
PMID:24412560
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
decreases expression
EXP
Erythromycin Estolate results in decreased expression of ALDH3A2 mRNA
CTD
PMID:17522070
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of APEX1 mRNA
CTD
PMID:17522070
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Aspm
assembly factor for spindle microtubules
decreases expression increases expression
EXP
Erythromycin Estolate results in decreased expression of ASPM mRNA Erythromycin Estolate results in increased expression of ASPM mRNA
CTD
PMID:24412560
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
G
Aurkb
aurora kinase B
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of AURKB mRNA Erythromycin Estolate results in decreased expression of AURKB mRNA
CTD
PMID:24412560
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression
EXP
Erythromycin Estolate results in decreased expression of BAX mRNA
CTD
PMID:12883083
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
increases expression
EXP
Erythromycin Estolate results in increased expression of BCL2 mRNA
CTD
PMID:12883083
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Btg2
BTG anti-proliferation factor 2
increases expression
EXP
Erythromycin Estolate results in increased expression of BTG2 mRNA
CTD
PMID:17522070
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Cacna1i
calcium voltage-gated channel subunit alpha1 I
decreases expression
EXP
Erythromycin Estolate results in decreased expression of CACNA1I mRNA
CTD
PMID:24412560
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
G
Calu
calumenin
increases expression
EXP
Erythromycin Estolate results in increased expression of CALU mRNA
CTD
PMID:17522070
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Car1
carbonic anhydrase 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of CAR1 mRNA
CTD
PMID:24412560
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
G
Cat
catalase
decreases expression
EXP
Erythromycin Estolate results in decreased expression of CAT mRNA
CTD
PMID:17522070
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccn2
cellular communication network factor 2
decreases expression
EXP
Erythromycin Estolate results in decreased expression of CCN2 mRNA
CTD
PMID:24412560
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of CCNA2 mRNA Erythromycin Estolate results in decreased expression of CCNA2 mRNA
CTD
PMID:24412560
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression increases expression
EXP
Erythromycin Estolate results in decreased expression of CCNB1 mRNA Erythromycin Estolate results in increased expression of CCNB1 mRNA
CTD
PMID:24412560
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Cdca3
cell division cycle associated 3
decreases expression increases expression
EXP
Erythromycin Estolate results in decreased expression of CDCA3 mRNA Erythromycin Estolate results in increased expression of CDCA3 mRNA
CTD
PMID:24412560
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdk1
cyclin-dependent kinase 1
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of CDK1 mRNA Erythromycin Estolate results in decreased expression of CDK1 mRNA
CTD
PMID:24412560
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Ceacam1
CEA cell adhesion molecule 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of CEACAM1 mRNA
CTD
PMID:17522070
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
G
Cenpw
centromere protein W
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of CENPW mRNA Erythromycin Estolate results in decreased expression of CENPW mRNA
CTD
PMID:24412560
NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
G
Ces2h
carboxylesterase 2H
increases expression
EXP
Erythromycin Estolate results in increased expression of CES2 mRNA
CTD
PMID:24412560
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Chd2
chromodomain helicase DNA binding protein 2
increases expression
EXP
Erythromycin Estolate results in increased expression of CHD2 mRNA
CTD
PMID:24412560
NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502
G
Ctsl
cathepsin L
increases expression
EXP
Erythromycin Estolate results in increased expression of CTSL mRNA
CTD
PMID:17522070
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cyb5r3
cytochrome b5 reductase 3
decreases expression
EXP
Erythromycin Estolate results in decreased expression of CYB5R3 mRNA
CTD
PMID:17522070
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
EXP
Erythromycin Estolate results in increased expression of CYP1A1 mRNA
CTD
PMID:24412560
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2d3
cytochrome P450, family 2, subfamily d, polypeptide 3
decreases expression
EXP
Erythromycin Estolate results in decreased expression of CYP2D3 mRNA
CTD
PMID:17522070
NCBI chr 7:113,917,711...113,922,068
Ensembl chr 7:113,908,947...113,922,084
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
Erythromycin Estolate results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:12883083
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
EXP
Erythromycin Estolate results in increased expression of CYP3A9 mRNA
CTD
PMID:24412560
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
increases expression
EXP
Erythromycin Estolate results in increased expression of CYP8B1 mRNA
CTD
PMID:24412560
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Ddit3
DNA-damage inducible transcript 3
increases expression
EXP
Erythromycin Estolate results in increased expression of DDIT3 mRNA
CTD
PMID:17522070
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dut
deoxyuridine triphosphatase
increases expression
EXP
Erythromycin Estolate results in increased expression of DUT mRNA
CTD
PMID:24412560
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
G
Ect2
epithelial cell transforming 2
decreases expression increases expression
EXP
Erythromycin Estolate results in decreased expression of ECT2 mRNA Erythromycin Estolate results in increased expression of ECT2 mRNA
CTD
PMID:24412560
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
G
Fabp1
fatty acid binding protein 1
increases expression
EXP
Erythromycin Estolate results in increased expression of FABP1 mRNA
CTD
PMID:17522070
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fads1
fatty acid desaturase 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of FADS1 mRNA
CTD
PMID:17522070
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
G
Fam111a
FAM111 trypsin like peptidase A
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of FAM111A mRNA Erythromycin Estolate results in decreased expression of FAM111A mRNA
CTD
PMID:24412560
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
G
Fasn
fatty acid synthase
decreases expression
EXP
Erythromycin Estolate results in decreased expression of FASN mRNA
CTD
PMID:17522070
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fga
fibrinogen alpha chain
increases expression
EXP
Erythromycin Estolate results in increased expression of FGA mRNA
CTD
PMID:17522070
NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
G
Fgb
fibrinogen beta chain
increases expression
EXP
Erythromycin Estolate results in increased expression of FGB mRNA
CTD
PMID:17522070
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of FMO1 mRNA
CTD
PMID:17522070
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of G6PC1 mRNA
CTD
PMID:24412560
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
EXP
Erythromycin Estolate results in increased expression of GADD45A mRNA
CTD
PMID:17522070
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gck
glucokinase
decreases expression
EXP
Erythromycin Estolate results in decreased expression of GCK mRNA
CTD
PMID:17522070
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
G
Gpx1
glutathione peroxidase 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of GPX1 mRNA
CTD
PMID:17522070
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
increases expression
EXP
Erythromycin Estolate results in increased expression of GPX2 mRNA
CTD
PMID:24412560
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gstm5
glutathione S-transferase, mu 5
decreases expression
EXP
Erythromycin Estolate results in decreased expression of GSTM3 mRNA
CTD
PMID:17522070
NCBI chr 2:195,531,627...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Hibadh
3-hydroxyisobutyrate dehydrogenase
decreases expression
EXP
Erythromycin Estolate results in decreased expression of HIBADH mRNA
CTD
PMID:17522070
NCBI chr 4:81,649,180...81,747,244
Ensembl chr 4:81,649,175...81,780,617
G
Hmmr
hyaluronan-mediated motility receptor
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of HMMR mRNA Erythromycin Estolate results in decreased expression of HMMR mRNA
CTD
PMID:24412560
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
G
Igf2r
insulin-like growth factor 2 receptor
increases expression
EXP
Erythromycin Estolate results in increased expression of IGF2R mRNA
CTD
PMID:24412560
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression
EXP
Erythromycin Estolate results in increased expression of IGFBP1 mRNA
CTD
PMID:17522070
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Igfbp2
insulin-like growth factor binding protein 2
increases expression
EXP
Erythromycin Estolate results in increased expression of IGFBP2 mRNA
CTD
PMID:24412560
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Ip6k2
inositol hexakisphosphate kinase 2
decreases expression
EXP
Erythromycin Estolate results in decreased expression of IP6K2 mRNA
CTD
PMID:24412560
NCBI chr 8:109,483,843...109,510,172
Ensembl chr 8:109,484,310...109,510,166
G
Isy1
ISY1 splicing factor homolog
increases expression
EXP
Erythromycin Estolate results in increased expression of ISY1 mRNA
CTD
PMID:24412560
NCBI chr 4:120,276,535...120,297,227
Ensembl chr 4:120,276,292...120,297,188
G
Kif20b
kinesin family member 20B
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of KIF20B mRNA Erythromycin Estolate results in decreased expression of KIF20B mRNA
CTD
PMID:24412560
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
G
Kif23
kinesin family member 23
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of KIF23 mRNA Erythromycin Estolate results in decreased expression of KIF23 mRNA
CTD
PMID:24412560
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
G
Kif2c
kinesin family member 2C
decreases expression increases expression
EXP
Erythromycin Estolate results in decreased expression of KIF2C mRNA Erythromycin Estolate results in increased expression of KIF2C mRNA
CTD
PMID:24412560
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Krt18
keratin 18
increases expression
EXP
Erythromycin Estolate results in increased expression of KRT18 mRNA
CTD
PMID:17522070
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Lbp
lipopolysaccharide binding protein
increases expression
EXP
Erythromycin Estolate results in increased expression of LBP mRNA
CTD
PMID:17522070
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lgals3
galectin 3
increases expression
EXP
Erythromycin Estolate results in increased expression of LGALS3 mRNA
CTD
PMID:17522070
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Lipc
lipase C, hepatic type
decreases expression
EXP
Erythromycin Estolate results in decreased expression of LIPC mRNA
CTD
PMID:17522070
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
G
Lpin1
lipin 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of LPIN1 mRNA
CTD
PMID:24412560
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lpl
lipoprotein lipase
increases expression
EXP
Erythromycin Estolate results in increased expression of LPL mRNA
CTD
PMID:17522070
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Maob
monoamine oxidase B
decreases expression
EXP
Erythromycin Estolate results in decreased expression of MAOB mRNA
CTD
PMID:17522070
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Mir16
microRNA 16
increases expression
EXP
Erythromycin Estolate results in increased expression of MIR16 mRNA
CTD
PMID:17522070
NCBI chr 2:153,245,349...153,245,443
Ensembl chr 2:153,245,349...153,245,443
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of MYC mRNA Erythromycin Estolate results in decreased expression of MYC mRNA
CTD
PMID:17522070 PMID:24412560
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Ncaph
non-SMC condensin I complex, subunit H
decreases expression increases expression
EXP
Erythromycin Estolate results in decreased expression of NCAPH mRNA Erythromycin Estolate results in increased expression of NCAPH mRNA
CTD
PMID:24412560
NCBI chr 3:114,371,937...114,399,223
Ensembl chr 3:114,371,941...114,399,180
G
Nfkbib
NFKB inhibitor beta
decreases expression
EXP
Erythromycin Estolate results in decreased expression of NFKBIB mRNA
CTD
PMID:17522070
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
G
Noct
nocturnin
decreases expression
EXP
Erythromycin Estolate results in decreased expression of NOCT mRNA
CTD
PMID:24412560
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
G
Nusap1
nucleolar and spindle associated protein 1
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of NUSAP1 mRNA Erythromycin Estolate results in decreased expression of NUSAP1 mRNA
CTD
PMID:24412560
NCBI chr 3:106,603,273...106,633,624
Ensembl chr 3:106,603,289...106,633,624
G
Obp3
alpha-2u globulin PGCL4
decreases expression
EXP
Erythromycin Estolate results in decreased expression of OBP3 mRNA
CTD
PMID:24412560
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
G
Otc
ornithine transcarbamylase
decreases expression
EXP
Erythromycin Estolate results in decreased expression of OTC mRNA
CTD
PMID:17522070
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
G
Pclaf
PCNA clamp associated factor
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of PCLAF mRNA Erythromycin Estolate results in decreased expression of PCLAF mRNA
CTD
PMID:24412560
NCBI chr 8:66,420,673...66,432,568
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
G
Pcmtd1
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of PCMTD1 mRNA
CTD
PMID:24412560
NCBI chr 5:12,284,711...12,355,680
Ensembl chr 5:12,284,711...12,354,899
G
Pdk4
pyruvate dehydrogenase kinase 4
decreases expression
EXP
Erythromycin Estolate results in decreased expression of PDK4 mRNA
CTD
PMID:24412560
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Per1
period circadian regulator 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of PER1 mRNA
CTD
PMID:24412560
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
decreases expression
EXP
Erythromycin Estolate results in decreased expression of PFKFB3 mRNA
CTD
PMID:24412560
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
G
Pklr
pyruvate kinase L/R
decreases expression
EXP
Erythromycin Estolate results in decreased expression of PKLR mRNA
CTD
PMID:17522070
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
G
Pygl
glycogen phosphorylase L
decreases expression
EXP
Erythromycin Estolate results in decreased expression of PYGL mRNA
CTD
PMID:17522070
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Rad51
RAD51 recombinase
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of RAD51 mRNA Erythromycin Estolate results in decreased expression of RAD51 mRNA
CTD
PMID:24412560
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression increases expression
EXP
Erythromycin Estolate results in decreased expression of RRM2 mRNA Erythromycin Estolate results in increased expression of RRM2 mRNA
CTD
PMID:24412560
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
S100a8
S100 calcium binding protein A8
increases expression
EXP
Erythromycin Estolate results in increased expression of S100A8 mRNA
CTD
PMID:17522070
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
EXP
Erythromycin Estolate results in increased expression of S100A9 mRNA
CTD
PMID:17522070
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Serpina7
serpin family A member 7
increases expression
EXP
Erythromycin Estolate results in increased expression of SERPINA7 mRNA
CTD
PMID:24412560
NCBI chr X:102,663,242...102,722,319
Ensembl chr X:102,663,405...102,669,040
G
Sertad3
SERTA domain containing 3
increases expression
EXP
Erythromycin Estolate results in increased expression of SERTAD3 mRNA
CTD
PMID:24412560
NCBI chr 1:82,763,535...82,767,271
Ensembl chr 1:82,763,149...82,769,001
G
Shcbp1
SHC binding and spindle associated 1
decreases expression increases expression
EXP
Erythromycin Estolate results in decreased expression of SHCBP1 mRNA Erythromycin Estolate results in increased expression of SHCBP1 mRNA
CTD
PMID:24412560
NCBI chr16:84,672,276...84,703,839
Ensembl chr16:84,672,321...84,703,844
G
Slc38a2
solute carrier family 38, member 2
decreases expression
EXP
Erythromycin Estolate results in decreased expression of SLC38A2 mRNA
CTD
PMID:24412560
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
increases expression
EXP
Erythromycin Estolate results in increased expression of SLCO1A4 mRNA
CTD
PMID:24412560
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Slco1b2
solute carrier organic anion transporter family member 1B2
decreases expression
EXP
Erythromycin Estolate results in decreased expression of SLCO1B2 mRNA
CTD
PMID:17522070
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Spc25
SPC25 component of NDC80 kinetochore complex
increases expression decreases expression
EXP
Erythromycin Estolate results in increased expression of SPC25 mRNA Erythromycin Estolate results in decreased expression of SPC25 mRNA
CTD
PMID:24412560
NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959
G
Spin2b
spindlin family member 2B
decreases expression
EXP
Erythromycin Estolate results in decreased expression of SPIN2B mRNA
CTD
PMID:17522070
NCBI chr X:17,190,371...17,192,351
Ensembl chr X:17,180,474...17,192,351
G
Spink1
serine peptidase inhibitor, Kazal type 1
increases expression
EXP
Erythromycin Estolate results in increased expression of SPINK1 mRNA
CTD
PMID:24412560
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of SREBF1 mRNA
CTD
PMID:17522070
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Stat3
signal transducer and activator of transcription 3
increases expression
EXP
Erythromycin Estolate results in increased expression of STAT3 mRNA
CTD
PMID:17522070
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Styxl1
serine/threonine/tyrosine interacting-like 1
increases expression
EXP
Erythromycin Estolate results in increased expression of STYXL1 mRNA
CTD
PMID:24412560
NCBI chr12:20,907,410...20,940,232
Ensembl chr12:20,907,435...20,939,752
G
Sugt1
SGT1 homolog, MIS12 kinetochore complex assembly cochaperone
increases expression
EXP
Erythromycin Estolate results in increased expression of SUGT1 mRNA
CTD
PMID:24412560
NCBI chr15:54,991,419...55,032,244
Ensembl chr15:54,990,672...55,069,150
G
Tgfb3
transforming growth factor, beta 3
decreases expression
EXP
Erythromycin Estolate results in decreased expression of TGFB3 mRNA
CTD
PMID:24412560
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Thrsp
thyroid hormone responsive
decreases expression
EXP
Erythromycin Estolate results in decreased expression of THRSP mRNA
CTD
PMID:17522070
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
EXP
Erythromycin Estolate results in increased expression of TIMP1 mRNA
CTD
PMID:17522070
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tmcc1
transmembrane and coiled-coil domain family 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of TMCC1 mRNA
CTD
PMID:24412560
NCBI chr 4:149,069,252...149,239,585
Ensembl chr 4:149,069,260...149,239,620
G
Tnfaip3
TNF alpha induced protein 3
decreases expression
EXP
Erythromycin Estolate results in decreased expression of TNFAIP3 mRNA
CTD
PMID:24412560
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
EXP
Erythromycin Estolate results in increased expression of TNFRSF1A mRNA
CTD
PMID:17522070
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tp53
tumor protein p53
decreases expression
EXP
Erythromycin Estolate results in decreased expression of TP53 mRNA
CTD
PMID:17522070
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tsc22d3
TSC22 domain family, member 3
decreases expression
EXP
Erythromycin Estolate results in decreased expression of TSC22D3 mRNA
CTD
PMID:24412560
NCBI chr X:104,217,898...104,277,935
Ensembl chr X:104,217,925...104,276,861
G
Ttr
transthyretin
decreases expression
EXP
Erythromycin Estolate results in decreased expression of TTR mRNA
CTD
PMID:17522070
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Txnrd1
thioredoxin reductase 1
decreases expression
EXP
Erythromycin Estolate results in decreased expression of TXNRD1 mRNA
CTD
PMID:17522070
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ugt2a1
UDP glucuronosyltransferase family 2 member A1
increases expression
EXP
Erythromycin Estolate results in increased expression of UGT2A1 mRNA
CTD
PMID:24412560
NCBI chr14:20,521,018...20,545,060
Ensembl chr14:20,517,951...20,545,531
G
Zc3h13
zinc finger CCCH type containing 13
increases expression
EXP
Erythromycin Estolate results in increased expression of ZC3H13 mRNA
CTD
PMID:24412560
NCBI chr15:50,607,335...50,671,802
Ensembl chr15:50,607,380...50,671,802
G
Zfp354a
zinc finger protein 354A
decreases expression
EXP
Erythromycin Estolate results in decreased expression of ZFP354A mRNA
CTD
PMID:24412560
NCBI chr10:35,396,242...35,408,065
Ensembl chr10:35,396,231...35,408,068
G
Zfp574
zinc finger protein 574
increases expression
EXP
Erythromycin Estolate results in increased expression of ZFP574 mRNA
CTD
PMID:24412560
NCBI chr 1:80,667,984...80,678,257
Ensembl chr 1:80,664,259...80,679,427
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all